by Stacey Hawkins | May 25, 2020 | Drug Discovery
When popping a pill, how often do we think about what happens next—to the pill, or to our bodies? Maybe we assume the body welcomes any extra help to soothe our headache or control our blood pressure. This WEEKLY looks into the mystery of what comes after the swallow.... 
by Stacey Hawkins | Apr 14, 2020 | Neuroscience
Multiple SCLEROSIS Awareness March is Multiple Sclerosis (MS) Awareness Month, so this WEEKLY takes a look at the science behind the disease and some of the treatments developed for it. MS typically occurs in susceptible individuals between the ages of 20 and 50, and... 
by Stacey Hawkins | Oct 14, 2019 | Front Page Feature
Every Breath You take Did you know that we breathe in and out about 22,000 times every day? It takes that much effort to obtain the oxygen we need to function. Oxygen drives cellular respiration, the process by which cells transform food into the energy our bodies... 
by Stacey Hawkins | Jun 26, 2019 | Oncology
Keeping Cancer In The Crosshairs With Targeted Therapies One of the biggest stories in last week’s biotech news headlines was Pfizer’s (New York, NY) acquisition of Array Biopharma (Boulder, CO) for the tidy sum of $11 billion. Array specializes in targeted cancer... 
by Stacey Hawkins | Dec 20, 2018 | Precision Medicine
FOUR MOLECULAR VARIANTS EXPLAINED Hearing your doctor utter the words HER2-positive, HR-positive, triple-negative, or BRCA mutation can be devastating — even for the most resilient person. Simply put, breast cancer is a complex disease. A diagnosis can be derived...
